Article | March 10, 2026

Your Asset Data Determines Your Implementation Timeline

data-driven-biotech-GettyImages-2240941809

Platform capability and team experience matter less than most project plans assume. In regulated manufacturing, the schedule risk often sits in the asset records themselves: overlapping sources, conflicting classifications, and calibration intervals no one can justify. Data readiness works better as its own workstream than as a configuration task. Naming conventions, preventive maintenance frequencies, and calibration logic cause the most disruption, and a stripped-down set of day-one fields may serve a go-live better than a complete migration. A 90-day plan in three phases ties data decisions to validation, audit readiness, and Annex 11 migration expectations. Explore the plan to see how the work is sequenced.

Access The Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online